Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
White Paper
Essentials of Return to Work Series
At Enlyte, we understand that a suc
APAX
News Release
Funds advised by Apax Partners acquire GENEX Services
https://www.apax.com/news-views/funds-advised-by-apax-partners-acquire-genex-services/
WorkCompWire
Article
4 For 14 Interview with Ron Skrocki
Workers' Comp
News Release
Genex Wins Communitas Award for Corporate Social Responsibility
WAYNE, Pa. – March 5, 2014 – Genex Services, Inc.
Mitchell
Case Study
Case Study: Young Shop Owners Credit Mitchell as Their 10th Employee
Mitchell
Case Study